ACRODAT® focuses on five disease-specific parameters (IGF-I, tumor size, comorbidities, acromegaly related symptoms, and quality of life, QoL) to estimate disease activity in patients with acromegaly. The gene discussed is IGF1; the disease is acromegaly.